Subclinical Atherosclerosis, Cardiac and Kidney Function, Heart Failure, and Dementia in the Very Elderly

Lewis H Kuller1, Oscar L Lopez2,3, John S Gottdiener4

  • 1Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, PA kullerl@edc.pitt.edu.

Insights

Biomarkers like high-sensitivity cardiac troponin T and coronary artery calcium may predict dementia risk in older adults. Lower levels of these markers are associated with a reduced risk of dementia and heart failure (HF).

Area of Science:

  • Cardiology
  • Neurology
  • Geriatrics

Background:

  • Heart failure (HF) and dementia are leading causes of disability and death in the elderly.
  • Cardiovascular disease (CVD) biomarkers may influence dementia risk in older populations.
  • This study investigated the relationship between CVD and HF biomarkers and the risk of dementia and mortality.

Purpose of the Study:

  • To test if biomarkers like high-sensitivity cardiac troponin T (hs-cTnT), N-terminal of prohormone brain natriuretic peptide (NT-proBNP), and cystatin C predict risks of death, CVD, HF, and dementia.
  • To examine if CVD biomarkers increase HF risk, subsequently increasing dementia risk.
  • To determine if a combination of low coronary artery calcium (CAC), low atherosclerosis, and low hs-cTnT (myocardial injury) reduces dementia risk.

Main Methods:

  • Utilized data from the Cardiovascular Health Study Cognition Study (Pittsburgh site, 1998-2014).
  • Included 532 participants from the original cohort (924 total), with baseline brain MRI in 1992-1994.
  • Analyzed 120 incident HF cases and dementia diagnoses, noting the timing of onset.

Main Results:

  • Among 532 participants, 120 developed HF, and 72% of these also had dementia.
  • In most cases (80 of 87), dementia preceded the diagnosis of HF.
  • A combination of low CAC score and low hs-cTnT was significantly associated with a reduced risk of both dementia and HF.

Conclusions:

  • Dementia frequently co-occurred with HF, often preceding it.
  • Lower levels of hs-cTnT and CAC were linked to a lower risk of dementia, although based on a limited number of events.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
629
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
768
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
605
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
474